Korro Bio, Inc.

KRROReported to SECin USCIK 0001703647Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 24. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 24
Form 4 lines at Korro Bio, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
FORMELA JEAN FRANCOIS—Open-market sell$93,2206,602 sharesSep 15, 2026FORMELA JEAN FRANCOIS$93,220Sell · Sep 15Open-market sell6,602Sep 15, 2026
FORMELA JEAN FRANCOIS—Open-market sell$450,25931,888 sharesSep 15, 2026FORMELA JEAN FRANCOIS$450,259Sell · Sep 15Open-market sell31,888Sep 15, 2026
FORMELA JEAN FRANCOIS—Open-market sell$24,4831,750 sharesSep 15, 2026FORMELA JEAN FRANCOIS$24,483Sell · Sep 15Open-market sell1,750Sep 15, 2026
FORMELA JEAN FRANCOIS—Open-market sell$118,2168,450 sharesSep 15, 2026FORMELA JEAN FRANCOIS$118,216Sell · Sep 15Open-market sell8,450Sep 15, 2026
Dolan OliverSenior Vice President, FinanceOpen-market sell$695 sharesSep 14, 2026Dolan OliverSenior Vice President, Finance$69Sell · Sep 14Open-market sell5Sep 14, 2026